Home » Topics » BioWorld Science

BioWorld Science
RSS

NS-1201 available for licensing

Oct. 25, 1996

Daiichi reports calmodulin inhibitors

Oct. 25, 1996

SCRAS claims NOS inhibitors

Oct. 25, 1996

Glaxo Wellcome claims NMDA antagonists

Oct. 25, 1996

Twenty-four drugs in development for Alzheimer's disease in U.S.

Oct. 25, 1996

Two Alzheimer's drugs in phase III in Japan

Oct. 25, 1996

Spotlight on ALS research

Oct. 25, 1996

Cephalosporin tested in Italian patients with ALS

Oct. 25, 1996

Talipexole now available in Japan

Oct. 25, 1996

Company Profile: Variagenics

Oct. 25, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 6, 2026.
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...
CROI 2026 highlights depression and cognitive vulnerability in HIV
BioWorld
The effects of aging pose an additional challenge for people with HIV due to the neurological and psychological consequences that persist despite antiretroviral...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
Slate Medicines launches with focus on headache disorders
BioWorld Science
Slate Medicines Inc. has launched with $130 million in series A financing and a focus on advancing next-generation therapeutics for migraine and other headache...